Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Dridi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Chemical Neuroanatomy|August 21, 2007
L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeysPhilippe Huot, Martin Lévesque, Marc Morissette, et al.
Brain : a Journal of Neurology|March 23, 2004
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesiasFrédéric Calon, Mehdi Dridi, Oleh Hornykiewicz, et al.
Journal of Biomolecular Structure & Dynamics|January 11, 2014
Structural insight into the binding complex: β-arrestin/CCR5 complexNejla Stambouli, Mehdi Dridi, Ning-Ning Wei, et al.
Marine Biotechnology (New York, N.Y.)|January 19, 2018
Phytochemical Analysis and Evaluation of the Antioxidant, Anti-Inflammatory, and Antinociceptive Potential of Phlorotannin-Rich Fractions from Three Mediterranean Brown SeaweedsAmal Abdelhamid, Meriem Jouini, Haifa Bel Haj Amor, et al.
Synapse (New York, N.Y.)|June 2, 2006
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptorsMarc Morissette, Mehdi Dridi, Frédéric Calon, et al.
Journal of Molecular Neuroscience : MN|August 16, 2008
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesiasBazoumana Ouattara, Samah Belkhir, Marc Morissette, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2005
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalinMarc Morissette, Mehdi Dridi, Frédéric Calon, et al.
Neuropharmacology|November 16, 2007
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesiasPershia Samadi, Laurent Grégoire, Marc Morissette, et al.
Synapse (New York, N.Y.)|November 10, 2007
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeysPershia Samadi, Marc Morissette, Fréderic Calon, et al.
Neurobiology of Aging|March 14, 2007
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeysPershia Samadi, Laurent Grégoire, Marc Morissette, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Chemical Neuroanatomy|August 21, 2007
L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeysPhilippe Huot, Martin Lévesque, Marc Morissette, et al.
Brain : a Journal of Neurology|March 23, 2004
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesiasFrédéric Calon, Mehdi Dridi, Oleh Hornykiewicz, et al.
Journal of Biomolecular Structure & Dynamics|January 11, 2014
Structural insight into the binding complex: β-arrestin/CCR5 complexNejla Stambouli, Mehdi Dridi, Ning-Ning Wei, et al.
Marine Biotechnology (New York, N.Y.)|January 19, 2018
Phytochemical Analysis and Evaluation of the Antioxidant, Anti-Inflammatory, and Antinociceptive Potential of Phlorotannin-Rich Fractions from Three Mediterranean Brown SeaweedsAmal Abdelhamid, Meriem Jouini, Haifa Bel Haj Amor, et al.
Synapse (New York, N.Y.)|June 2, 2006
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptorsMarc Morissette, Mehdi Dridi, Frédéric Calon, et al.
Journal of Molecular Neuroscience : MN|August 16, 2008
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesiasBazoumana Ouattara, Samah Belkhir, Marc Morissette, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2005
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalinMarc Morissette, Mehdi Dridi, Frédéric Calon, et al.
Neuropharmacology|November 16, 2007
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesiasPershia Samadi, Laurent Grégoire, Marc Morissette, et al.
Synapse (New York, N.Y.)|November 10, 2007
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeysPershia Samadi, Marc Morissette, Fréderic Calon, et al.
Neurobiology of Aging|March 14, 2007
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeysPershia Samadi, Laurent Grégoire, Marc Morissette, et al.
Pageof 1